The Czech Ministry of Health (“MoH”) is currently working on a draft legislation implementing an emergency distribution system (inspired by the Slovakia where something similar was introduced in April last year) that should, in the opinion of the MoH, prevent re-export of medicinal products from the Czech Republic and improve availability of the medicinal products on the Czech market.
Z przyjemnością informujemy, że właśnie ukazała się publikacja pt. Distribution and marketing of drugs in Poland: overview przygotowana przez ekspertów Praktyki Life Sciences: Marcina Matczaka, Tomasza Kaczyńskiego i Krzysztofa Kumalę. Publikacja została wydana przez Thomson Reuters – Practical Law Global Guides. Publikacja jest przeglądem najważniejszych wątków prawnych i biznesowych dotyczących […]
Z przyjemnością informujemy, że właśnie ukazała się publikacja przygotowana przez ekspertów z Praktyki Life Sciences pt. „Commercialisation of healthcare in Poland: overview”. Autorami są: Marcin Matczak, Tomasz Kaczyński i Krzysztof Kumala. Publikacja została wydana przez Thomson Reuters – Practical Law Global Guides.
Chambers & Partners have just published the new edition of „Legal Practice Guides – Life Sciences”. The Guide contains articles written by Dr. hab. Marcin Matczak, Tomasz Kaczyński and Michał Czarnuch on legal and business issues that are key to the life sciences sector in Poland. Information has been comprehensively […]
Conventional medicinal products derived from chemical processes can generally be divided into innovative and generic. Innovative medicinal products are those that have no equivalent on the market, carry patents, and a decision to market them depends to a great extent on an analysis of clinical trial results. However, a generic […]
On 22 December 2010, the European Court of Justice (“ECJ”) issued a judgment in European Commission v. The Republic of Poland (C-385/08) in which it found that Poland was in breach of European Union law. The breach involved generics of the medicine Plavix being introduced to trade and marketed after […]
In the evening of 9 September 2010, a proposed act on the reimbursement of drugs, foodstuffs intended for particular nutritional purposes and medical devices was sent for interministerial and public consultation (bill of 8 September 2010; further: the Reimbursement Act). The proposed amendments are revolutionary and could lead to a […]
